← Back to patent-cliff list
CAS 26033-20-5
3-Phenyl-1H-pyrazole-4-carbaldehyde
Codes: (XV) 920279-2-b, (XIII) 920279-3-a, (V) 920279-4-a
Application context (from source-drug indications)
Non-small cell lung cancerLazertinib MesylateHepatic function declineLazertinib Mesylate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Lazertinib Mesylate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
1-(2-Chloropyrimidin-4-yl)-3-phenyl-1H-pyrazole-4-carbaldehyde→2-Chloropyrimidin-4-yl chloride→3-Phenyl-1H-pyrazole-4-carbaldehyde
2-Amino-5-fluoro-4-nitroanisole→1-Oxa-4-azacyclohexane→2-Methoxy-4-(morpholin-4-yl)-5-nitroaniline→2-Methoxy-4-morpholin-4-yl-5-nitrophenylformamide→5-Amino-2-methoxy-4-morpholin-4-ylphenylformamide→(Chloromethyl)acetyl chloride→3-Chloro-N-[5-formamido-4-methoxy-2-(morpholin-4-yl)phenyl]propanamide→N-[5-(Formylamino)-4-methoxy-2-morpholin-4-ylphenyl]acrylamide→1-[2-(Methanesulfonyl)pyrimidin-4-yl]-3-phenyl-1H-pyrazole-4-carbaldehyde→N-[5-[[4-(4-Formyl-3-phenyl-1H-pyrazol-1-yl)pyrimidin-2-yl]amino]-4-methoxy-2-(morpholin-4-yl)phenyl]prop-2-enamide→Dimethylamine hydrochloride→N-[5-[(4-[4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]pyrimidin-2-yl)amino]-4-methoxy-2-(morpholin-4-yl)phenyl]prop-2-enamide→3-Phenyl-1H-pyrazole-4-carbaldehyde→4-Chloro-2-(methylsulfanyl)pyrimidine→1-[2-(Methylsulfanyl)pyrimidin-4-yl]-3-phenyl-1H-pyrazole-4-carbaldehyde
4-Chloro-2-(methylsulfanyl)pyrimidine→4-Chloro-2-(methanesulfonyl)pyrimidine→2-Methoxy-4-morpholin-4-yl-5-nitrophenylformamide→4-Chloro-N-[2-methoxy-4-(morpholin-4-yl)-5-nitrophenyl]pyrimidin-2-amine→3-Phenyl-1H-pyrazole-4-carbaldehyde→1-[2-[2-Methoxy-4-(morpholin-4-yl)-5-nitroanilino]pyrimidin-4-yl]-3-phenyl-1H-pyrazole-4-carbaldehyde→1-[2-(Methanesulfonyl)pyrimidin-4-yl]-3-phenyl-1H-pyrazole-4-carbaldehyde→Dimethylamine hydrochloride→4-[4-[(Dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]-N-[2-methoxy-4-(morpholin-4-yl)-5-nitrophenyl]pyrimidin-2-amine→N1-[4-[4-[(Dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]pyrimidin-2-yl]-6-methoxy-4-(morpholin-4-yl)benzene-1,3-diamine→(Chloromethyl)acetyl chloride→3-Bromopropanoyl chloride→3-Chloro-N-[5-[(4-[4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]pyrimidin-2-yl)amino]-4-methoxy-2-(morpholin-4-yl)phenyl]propanamide→3-Bromo-N-[5-[(4-[4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]pyrimidin-2-yl)amino]-4-methoxy-2-(morpholin-4-yl)phenyl]propanamide→N-[5-[(4-[4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]pyrimidin-2-yl)amino]-4-methoxy-2-(morpholin-4-yl)phenyl]prop-2-enamide
Intermediates available on this site
Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.
| Supplier | Product | Price band | MOQ | Lead time | Qualifications | Action |
|---|---|---|---|---|---|---|
| Unibest Nantong cGMP Site | 3-phenyl-1H-pyrazole-4-carbaldehyde Pharmaceutical Intermediates | On request | On request | On request | — |
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.